About Us
Megadalton Solutions is located in Bloomington, IN and was founded based on technology developed at Indiana University.
Martin F. Jarrold
Chief Executive Officer
Martin F. Jarrold, Ph.D. is a professor and Robert and Marjorie Mann Chair at Indiana University. He started working on CDMS in 2006. Since then he introduced numerous technical improvements that have increased the sensitivity and accuracy of CDMS by orders of magnitude. Martin’s research group has two state-of-the-art CDMS instruments that have successfully been used in collaborations with more than twenty five research groups around the world. Collaborations have included a wide range of molecules including: protein complexes, viruses, nanoparticles, and lipoproteins to name a few. Altogether, he has over 30 papers published on instrumentation and applications of CDMS.
David E. Clemmer
Chief Operating Officer
David Clemmer, Ph.D. is a distinguished professor and Robert and Marjorie Mann Chair at Indiana University. He has substantial experience in commercialization of new technologies, and has taken on a number of non-academic roles, including: David was a scientific cofounder and advisor for Beyond Genomics, that went public on the NASDAQ in 2011; he helped translate nested-IMS-MS technologies from his academic lab to the Waters Corporation, which produced the first commercial high definition mass spectrometry (HDMS) instrument. David currently holds ~45 patents (including worldwide filings) and in 2017 he was elected as a fellow of the National Academy of Inventors.
Benjamin E Draper
Analytical Lead
Benjamin Draper completed his doctoral work in 2018 under Martin Jarrold at Indiana University working on the development of CDMS. As part of his doctoral work he streamlined CDMS data handling and improved detection sensitivity. CDMS can now measure down to femtomolar concentrations of megadalton sized species with data analysis in real-time. Recognizing the need for CDMS measurements to be commercially available, Benjamin joined Megadalton Solutions in 2018 to begin the commercialization of instrumentation, and provide accurate mass measurements for gene therapies to the pharmaceutical community.
Daniel Botamanenko
Instrumentation Lead
Daniel Botamanenko completed his doctoral work in 2021 under Martin Jarrold at Indiana University developing next-generation CD-MS detectors. Daniel is an expert in ion dynamics and ion trap design. Daniel joins Megadalton to lead innovation in CD-MS detector technology for ultra-high resolution mass measurements and facilitate co-development efforts with Waters.